Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Johnson Controls International plcJCI · Entity 2940 | VP & President, BTS EMEALA | December 07, 2022 | January 18, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Johnson Controls International plc
Report date December 07, 2022 · Filed January 18, 2023 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 45,718.45 |
Last balance in matching sequence
After 2022-12-08 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2022-12-07 · Grant · Acquired 16,136.85 · Balance 40,392.45 F1: This amendment is being filed to report transactions that were inadvertently omitted from the Form 4 filed on December 9, 2022 related to the vesting of PSUs and related tax withholdings. F2: Represents performance share units for the three-year performance period ended September 30, 2022. The Compensation Committee approved the performance results on November 28, 2022. Row 2 · 2022-12-07 · Tax withholding · Disposed 933 · Balance 39,459.45 Row 3 · 2022-12-08 · Tax withholding · Disposed 106 · Balance 39,353.45 Row 4 · 2022-12-08 · Grant · Acquired 6,365 · Balance 45,718.45 F3: Reflects grant of restricted share units that, subject to certain acceleration and forfeiture provisions, vest in three equal installments on each of the first, second and third anniversary of the grant date. Restricted share units accrue dividend equivalent units and convert to ordinary shares upon vesting. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.77 · Expires 2032-12-08 | Direct | 23,338 |
Reported balance
After 2022-12-08 transaction · row 5
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 5 · 2022-12-08 · Grant · Acquired 23,338 · Balance 23,338 F4: Subject to acceleration upon certain events, options become exercisable in two equal installments, on each of the second and third anniversary of grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: This amendment is being filed to report transactions that were inadvertently omitted from the Form 4 filed on December 9, 2022 related to the vesting of PSUs and related tax withholdings.
F2: Represents performance share units for the three-year performance period ended September 30, 2022. The Compensation Committee approved the performance results on November 28, 2022.
F3: Reflects grant of restricted share units that, subject to certain acceleration and forfeiture provisions, vest in three equal installments on each of the first, second and third anniversary of the grant date. Restricted share units accrue dividend equivalent units and convert to ordinary shares upon vesting.
F4: Subject to acceleration upon certain events, options become exercisable in two equal installments, on each of the second and third anniversary of grant date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Xylem Inc.
Report date September 27, 2019 · Filed September 30, 2019
Section 16 reporting ended · disclosed 2019-09-30. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2018 Filed Mar 6, 2018 20:13 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 3,986 | $35.96 | $143,336.56 |
DisclosureSEC source: 0001209191-18-017154 · doc4.xml · nonDerivative · entry 1 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2018 Filed Feb 27, 2018 23:26 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 225 | $76.41 | $17,192.25 |
DisclosureSEC source: 0001209191-18-014149 · doc4.xml · nonDerivative · entry 2 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,862 F2 · shares: Reflects the sale of shares of common stock to cover the tax liability incident to the vesting of restricted stock units granted on February 24, 2016 under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| February 27, 2018 Filed Feb 27, 2018 23:26 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 926 | $76.41 | $70,755.66 |
DisclosureSEC source: 0001209191-18-014149 · doc4.xml · nonDerivative · entry 1 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,087 F1 · shares: Reflects the sale of shares of common stock to cover the tax liability incident to the vesting of restricted stock units granted on February 24, 2015 under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 22:45 UTC | Xylem Inc. XYL · Entity 430 | GrantEmployee Stock Options (Right to Buy) · Derivative | 10,186 | $0.00 Strike: $75.18 | $0.00 |
DisclosureSEC source: 0001209191-18-013120 · doc4.xml · derivative · entry 3 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,186 Underlying: Common Stock · 10,186 shares Expires 2028-02-21 F3 · derivative.exercise_date: These options vest in three equal annual installments beginning on February 21, 2019. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 22:45 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 2,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013120 · doc4.xml · nonDerivative · entry 2 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,013 F2 · shares: Reflects an award of restricted stock units which are scheduled to vest in three equal annual installments beginning on February 21, 2019. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 22:45 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 290 | $75.83 | $21,990.70 |
DisclosureSEC source: 0001209191-18-013120 · doc4.xml · nonDerivative · entry 1 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,685 F1 · shares: Reflects the sale of shares of common stock to cover the tax liability incident to the vesting of restricted stock units granted on February 21, 2017 under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| December 19, 2017 Filed Dec 20, 2017 18:24 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 2,260 | $67.75 | $153,108.22 |
DisclosureSEC source: 0001209191-17-066603 · doc4.xml · nonDerivative · entry 1 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,975 F1 · shares: Reflects the sale of shares of common stock to cover the tax liability incident to the vesting of restricted stock units granted on December 18, 2014 under the Xylem 2011 Omnibus Incentive Plan. F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $67.70 to $67.83 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| May 04, 2017 Filed May 8, 2017 23:19 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,269 | $0.00 Strike: $38.76 | $0.00 |
DisclosureSEC source: 0001209191-17-030687 · doc4.xml · derivative · entry 10 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,269 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| May 04, 2017 Filed May 8, 2017 23:19 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,986 | $0.00 Strike: $35.96 | $0.00 |
DisclosureSEC source: 0001209191-17-030687 · doc4.xml · derivative · entry 9 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,986 Underlying: Common Stock · 3,986 shares Expires 2025-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| May 04, 2017 Filed May 8, 2017 23:19 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,772 | $0.00 Strike: $37.47 | $0.00 |
DisclosureSEC source: 0001209191-17-030687 · doc4.xml · derivative · entry 8 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,543 Underlying: Common Stock · 2,772 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| May 04, 2017 Filed May 8, 2017 23:19 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 5,053 | $50.35 | $254,430.17 |
DisclosureSEC source: 0001209191-17-030687 · doc4.xml · nonDerivative · entry 7 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,235 F2 · price: This price represents the weighted average price per Share of the Issuer, of sales that were executed at prices ranging from $50.31 to $50.44 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| May 04, 2017 Filed May 8, 2017 23:19 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 2,269 | $50.36 | $114,275.01 |
DisclosureSEC source: 0001209191-17-030687 · doc4.xml · nonDerivative · entry 6 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,288 F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $50.31 to $50.47 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| May 04, 2017 Filed May 8, 2017 23:19 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 2,269 | $38.76 | $87,946.44 |
DisclosureSEC source: 0001209191-17-030687 · doc4.xml · nonDerivative · entry 5 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,557 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2017 Filed May 8, 2017 23:19 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 3,986 | $50.36 | $200,749.31 |
DisclosureSEC source: 0001209191-17-030687 · doc4.xml · nonDerivative · entry 4 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,288 F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $50.31 to $50.47 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| May 04, 2017 Filed May 8, 2017 23:19 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 3,986 | $35.96 | $143,336.56 |
DisclosureSEC source: 0001209191-17-030687 · doc4.xml · nonDerivative · entry 3 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2017 Filed May 8, 2017 23:19 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 2,772 | $50.36 | $139,607.90 |
DisclosureSEC source: 0001209191-17-030687 · doc4.xml · nonDerivative · entry 2 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,288 F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $50.31 to $50.47 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| May 04, 2017 Filed May 8, 2017 23:19 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 2,772 | $37.47 | $103,866.84 |
DisclosureSEC source: 0001209191-17-030687 · doc4.xml · nonDerivative · entry 1 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 00:06 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 589 | $48.51 | $28,575.22 |
DisclosureSEC source: 0001209191-17-015472 · doc4.xml · nonDerivative · entry 2 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,288 F3 · shares: Reflects the sale of shares of common stock to cover the tax liability incident to the vesting of restricted stock units granted on February 25, 2014 under the Xylem 2011 Omnibus Incentive Plan. F4 · price: This price represents the approximate weighted average price per Share of the Issuer, of sales that were executed at prices ranging from $48.5135 to $48.515 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 00:06 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 230 | $48.30 | $11,110.10 |
DisclosureSEC source: 0001209191-17-015472 · doc4.xml · nonDerivative · entry 1 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,877 F1 · shares: Reflects the sale of shares of common stock to cover the tax liability incident to the vesting of restricted stock units granted on February 24, 2016 under the Xylem 2011 Omnibus Incentive Plan. F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $48.3034 to $48.305 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:59 UTC | Xylem Inc. XYL · Entity 430 | GrantEmployee Stock Options (Right to Buy) · Derivative | 11,737 | $0.00 Strike: $48.33 | $0.00 |
DisclosureSEC source: 0001209191-17-013854 · doc4.xml · derivative · entry 2 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,737 Underlying: Common Stock · 11,737 shares Expires 2027-02-21 F3 · derivative.exercise_date: These options vest in three equal annual installments beginning on February 21, 2018. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:59 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 2,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-013854 · doc4.xml · nonDerivative · entry 1 Brannemo Tomas · CIK 0001607927 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,107 F1 · shares: Reflects an award of restricted stock units which are scheduled to vest in three equal annual installments beginning on February 21, 2018. F2 · balance_after: Additional shares accrued through a qualified DRIP. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.